HCA Florida Northwest Hospital leads medical innovation with first-in-state procedure

HCA Florida Northwest Hospital, a leading healthcare institution in South Florida, proudly announces a groundbreaking advancement in urological care by introducing the Optilume® BPH Catheter System. Dr. Chris Hollowell, a distinguished urologist, performed the first surgery at HCA Florida Northwest Hospital, marking a significant milestone as the first HCA healthcare hospital to offer this revolutionary procedure.

Dr. Chris Hollowell, the urologist who performed the inaugural urological procedure, expressed, "This is a game-changer in the treatment of Benign Prostatic Hyperplasia. The immediate relief it provides and its minimal invasiveness marks a new era in urological care. We are proud to pioneer this technique at HCA Florida Northwest Hospital."

Kenneth Jones, CEO of HCA Florida Northwest Hospital, stated, "We are thrilled to be at the forefront of medical innovation by introducing this advanced technique for prostate care. This achievement reaffirms our commitment to providing our community with cutting-edge healthcare solutions."

The innovative urological treatment offers a 20-minute outpatient procedure, addressing the common issue of BPH affecting a significant percentage of aging men. This FDA-approved technology, a drug-coated balloon, provides immediate and lasting relief for lower urinary tract symptoms associated with BPH.

Key Highlights of Optilume BPH Catheter System:

• Clinically proven safe and effective
• Immediate and durable symptom relief
• Minimal catheter time post-procedure
• No impact on sexual function
• Quick recovery
• Highest clinically reported flow rates of any minimal invasive therapy
• In-office/outpatient procedure
• No cutting, heating, burning, lasering, steaming, or implantation